WGU D027 OBJECTIVE ASSESSMENT FINAL EXAM
2025/2026 COMPLETE QUESTIONS AND CORRECT
DETAILED ANSWERS WITH RATIONALES || 100%
GUARANTEED PASS!! <LATEST VERSION>
WGU D027 Advanced Pathopharmacological Foundations | Simulated Final
Assessment
Instructions: Select the single best Correct answer for each question. Questions
are designed to test application, analysis, and synthesis of advanced concepts.
Section 1: Complex Cardiovascular & Renal Integration
1. A 72-year-old patient with heart failure with reduced ejection fraction (HFrEF)
(LVEF 30%), hypertension, and stage 3b CKD (eGFR 38 mL/min) is on lisinopril,
metoprolol, and furosemide. They remain symptomatic. According to current
guidelines, which addition is most appropriate to reduce hospitalization and
mortality while considering renal function?
A. Add spironolactone.
B. Add digoxin.
C. Replace lisinopril with sacubitril/valsartan (ARNI).
D. Add ivabradine.
- Correct answer-: : C. Replace lisinopril with sacubitril/valsartan (ARNI).
Rationale: For symptomatic HFrEF on ACE-I/ARB, beta-blocker, and diuretic,
,guideline-directed medical therapy (GDMT) prioritizes switching to an ARNI (if
eGFR >30) due to superior mortality/morbidity reduction. Spironolactone (A) is
indicated but requires careful K+ monitoring in CKD. Digoxin (B) reduces
symptoms but not mortality. Ivabradine (D) is for HR >70 on max beta-blocker.
2. A patient with autosomal dominant polycystic kidney disease (ADPKD) and
rapidly declining renal function is started on tolvaptan. The nurse educates that
this drug slows cyst growth by:
A. Inhibiting the vasopressin V2 receptor, reducing intracellular cAMP.
B. Acting as a direct diuretic to dehydrate cysts.
C. Blocking the RAAS system.
D. Inhibiting mTOR signaling.
- Correct answer-: : A. Inhibiting the vasopressin V2 receptor.
Rationale: Tolvaptan is a selective V2 receptor antagonist. Vasopressin, via V2
receptors, stimulates cAMP in collecting duct cells, promoting cystogenesis and
fluid secretion. Blocking this pathway is disease-modifying in ADPKD. It causes
aquaresis, but that is a separate effect.
Section 2: Advanced Oncology & Targeted Therapy
3. A patient with metastatic non-small cell lung cancer (NSCLC) is found to have
an ALK gene rearrangement. First-line therapy would be:
A. Cisplatin + pemetrexed.
B. Pembrolizumab (if PD-L1 high).
C. Alectinib (a second-generation ALK inhibitor).
D. Erlotinib (an EGFR inhibitor).
- Correct answer-: : C. Alectinib.
Rationale: For ALK+ NSCLC, ALK tyrosine kinase inhibitors (TKIs) are first-line.
Alectinib (or brigatinib, lorlatinib) is preferred over the older crizotinib due to
superior CNS penetration and PFS. Chemotherapy (A) or immunotherapy (B) are
used in the absence of a targetable mutation.
4. A patient receiving high-dose methotrexate for osteosarcoma has delayed
renal clearance. To prevent severe toxicity, the nurse must ensure
administration of which rescue agent, and when should it be initiated?
A. Leucovorin, 24 hours after methotrexate starts, and continued until
methotrexate level is <0.1 µM.
,B. Glucarpidase, only if methotrexate levels are extremely high.
C. Fomepizole, to block alcohol dehydrogenase.
D. Sodium bicarbonate infusion to alkalinize urine only.
- Correct answer-: : A. Leucovorin, 24 hours after methotrexate starts.
Rationale: Leucovorin (folinic acid) is the standard rescue for methotrexate. It
provides a reduced form of folate that bypasses DHFR inhibition, "rescuing"
normal cells. Protocol typically starts it 24 hours after methotrexate initiation and
continues until the serum methotrexate level is in a safe range (<0.1 µM).
Glucarpidase (B) is for emergency rescue in renal failure.
Section 3: Pharmacogenomics & Adverse Drug Reactions
5. Prior to initiating azathioprine for inflammatory bowel disease, testing for
TPMT and NUDT15 genotype is recommended. A patient homozygous for a
NUDT15 loss-of-function allele is at extreme risk for:
A. Hepatotoxicity.
B. Severe, early-onset myelosuppression.
C. Pancreatitis.
D. Hypersensitivity syndrome.
- Correct answer-: : B. Severe, early-onset myelosuppression.
Rationale: NUDT15 polymorphisms (common in Asian populations) lead to
excessive accumulation of active thioguanine nucleotides, causing profound and
rapid bone marrow suppression even at standard doses. Testing guides dramatic
dose reduction or alternative therapy.
6. A patient of Southeast Asian descent is prescribed carbamazepine for
trigeminal neuralgia. Preemptive genotyping is recommended to identify a high
risk for which severe cutaneous adverse reaction?
A. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis, associated with HLA-
B*1502.
B. DRESS syndrome, associated with HLA-B*5701.
C. Acute interstitial nephritis.
D. QT prolongation.
- Correct answer-: : A. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Rationale: The **HLA-B*1502** allele, prevalent in Han Chinese and other Asian
populations, confers a vastly increased risk of life-threatening SJS/TEN with
, carbamazepine. FDA recommends testing patients of Asian ancestry before
initiation.
Section 4: Neuropharmacology & Psychiatry
7. A patient with Parkinson's disease on carbidopa/levodopa experiences
debilitating "off" periods and dyskinesias. Which advanced delivery method
provides continuous dopaminergic stimulation via intrajejunal infusion?
A. Deep brain stimulation (DBS).
B. Levodopa-carbidopa intestinal gel (LCIG).
C. Apomorphine subcutaneous injection.
D. Rotigotine transdermal patch.
- Correct answer-: : B. Levodopa-carbidopa intestinal gel (LCIG).
Rationale: LCIG is delivered via a pump directly into the jejunum, bypassing
erratic gastric emptying. This provides steady plasma levodopa levels, smoothing
motor fluctuations and reducing "off" time and dyskinesias in advanced PD. DBS
(A) is surgical.
8. For treatment-resistant major depressive disorder, intravenous ketamine is
used. Its rapid antidepressant effect is primarily attributed to:
A. Blockade of NMDA receptors on GABAergic interneurons, leading to a
glutamate surge and increased BDNF.
B. Direct agonism of serotonin 5-HT1A receptors.
C. Inhibition of monoamine oxidase.
D. Opiate receptor activation.
- Correct answer-: : A. Blockade of NMDA receptors.
Rationale: Ketamine's mechanism is unique. It blocks NMDA receptors on
inhibitory GABA neurons, causing disinhibition and a burst of glutamate. This
activates AMPA receptors, triggering BDNF release and synaptic plasticity in
mood-regulating circuits (mTOR pathway).
Section 5: Complex Infectious Disease & Stewardship
9. A patient with a history of recurrent Clostridioides difficile infection (rCDI) is
treated with fecal microbiota transplantation (FMT). The primary therapeutic
goal is to:
A. Directly deliver antibodies against C. difficile toxins.
B. Restore a diverse, protective gut microbiome to provide "colonization
2025/2026 COMPLETE QUESTIONS AND CORRECT
DETAILED ANSWERS WITH RATIONALES || 100%
GUARANTEED PASS!! <LATEST VERSION>
WGU D027 Advanced Pathopharmacological Foundations | Simulated Final
Assessment
Instructions: Select the single best Correct answer for each question. Questions
are designed to test application, analysis, and synthesis of advanced concepts.
Section 1: Complex Cardiovascular & Renal Integration
1. A 72-year-old patient with heart failure with reduced ejection fraction (HFrEF)
(LVEF 30%), hypertension, and stage 3b CKD (eGFR 38 mL/min) is on lisinopril,
metoprolol, and furosemide. They remain symptomatic. According to current
guidelines, which addition is most appropriate to reduce hospitalization and
mortality while considering renal function?
A. Add spironolactone.
B. Add digoxin.
C. Replace lisinopril with sacubitril/valsartan (ARNI).
D. Add ivabradine.
- Correct answer-: : C. Replace lisinopril with sacubitril/valsartan (ARNI).
Rationale: For symptomatic HFrEF on ACE-I/ARB, beta-blocker, and diuretic,
,guideline-directed medical therapy (GDMT) prioritizes switching to an ARNI (if
eGFR >30) due to superior mortality/morbidity reduction. Spironolactone (A) is
indicated but requires careful K+ monitoring in CKD. Digoxin (B) reduces
symptoms but not mortality. Ivabradine (D) is for HR >70 on max beta-blocker.
2. A patient with autosomal dominant polycystic kidney disease (ADPKD) and
rapidly declining renal function is started on tolvaptan. The nurse educates that
this drug slows cyst growth by:
A. Inhibiting the vasopressin V2 receptor, reducing intracellular cAMP.
B. Acting as a direct diuretic to dehydrate cysts.
C. Blocking the RAAS system.
D. Inhibiting mTOR signaling.
- Correct answer-: : A. Inhibiting the vasopressin V2 receptor.
Rationale: Tolvaptan is a selective V2 receptor antagonist. Vasopressin, via V2
receptors, stimulates cAMP in collecting duct cells, promoting cystogenesis and
fluid secretion. Blocking this pathway is disease-modifying in ADPKD. It causes
aquaresis, but that is a separate effect.
Section 2: Advanced Oncology & Targeted Therapy
3. A patient with metastatic non-small cell lung cancer (NSCLC) is found to have
an ALK gene rearrangement. First-line therapy would be:
A. Cisplatin + pemetrexed.
B. Pembrolizumab (if PD-L1 high).
C. Alectinib (a second-generation ALK inhibitor).
D. Erlotinib (an EGFR inhibitor).
- Correct answer-: : C. Alectinib.
Rationale: For ALK+ NSCLC, ALK tyrosine kinase inhibitors (TKIs) are first-line.
Alectinib (or brigatinib, lorlatinib) is preferred over the older crizotinib due to
superior CNS penetration and PFS. Chemotherapy (A) or immunotherapy (B) are
used in the absence of a targetable mutation.
4. A patient receiving high-dose methotrexate for osteosarcoma has delayed
renal clearance. To prevent severe toxicity, the nurse must ensure
administration of which rescue agent, and when should it be initiated?
A. Leucovorin, 24 hours after methotrexate starts, and continued until
methotrexate level is <0.1 µM.
,B. Glucarpidase, only if methotrexate levels are extremely high.
C. Fomepizole, to block alcohol dehydrogenase.
D. Sodium bicarbonate infusion to alkalinize urine only.
- Correct answer-: : A. Leucovorin, 24 hours after methotrexate starts.
Rationale: Leucovorin (folinic acid) is the standard rescue for methotrexate. It
provides a reduced form of folate that bypasses DHFR inhibition, "rescuing"
normal cells. Protocol typically starts it 24 hours after methotrexate initiation and
continues until the serum methotrexate level is in a safe range (<0.1 µM).
Glucarpidase (B) is for emergency rescue in renal failure.
Section 3: Pharmacogenomics & Adverse Drug Reactions
5. Prior to initiating azathioprine for inflammatory bowel disease, testing for
TPMT and NUDT15 genotype is recommended. A patient homozygous for a
NUDT15 loss-of-function allele is at extreme risk for:
A. Hepatotoxicity.
B. Severe, early-onset myelosuppression.
C. Pancreatitis.
D. Hypersensitivity syndrome.
- Correct answer-: : B. Severe, early-onset myelosuppression.
Rationale: NUDT15 polymorphisms (common in Asian populations) lead to
excessive accumulation of active thioguanine nucleotides, causing profound and
rapid bone marrow suppression even at standard doses. Testing guides dramatic
dose reduction or alternative therapy.
6. A patient of Southeast Asian descent is prescribed carbamazepine for
trigeminal neuralgia. Preemptive genotyping is recommended to identify a high
risk for which severe cutaneous adverse reaction?
A. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis, associated with HLA-
B*1502.
B. DRESS syndrome, associated with HLA-B*5701.
C. Acute interstitial nephritis.
D. QT prolongation.
- Correct answer-: : A. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Rationale: The **HLA-B*1502** allele, prevalent in Han Chinese and other Asian
populations, confers a vastly increased risk of life-threatening SJS/TEN with
, carbamazepine. FDA recommends testing patients of Asian ancestry before
initiation.
Section 4: Neuropharmacology & Psychiatry
7. A patient with Parkinson's disease on carbidopa/levodopa experiences
debilitating "off" periods and dyskinesias. Which advanced delivery method
provides continuous dopaminergic stimulation via intrajejunal infusion?
A. Deep brain stimulation (DBS).
B. Levodopa-carbidopa intestinal gel (LCIG).
C. Apomorphine subcutaneous injection.
D. Rotigotine transdermal patch.
- Correct answer-: : B. Levodopa-carbidopa intestinal gel (LCIG).
Rationale: LCIG is delivered via a pump directly into the jejunum, bypassing
erratic gastric emptying. This provides steady plasma levodopa levels, smoothing
motor fluctuations and reducing "off" time and dyskinesias in advanced PD. DBS
(A) is surgical.
8. For treatment-resistant major depressive disorder, intravenous ketamine is
used. Its rapid antidepressant effect is primarily attributed to:
A. Blockade of NMDA receptors on GABAergic interneurons, leading to a
glutamate surge and increased BDNF.
B. Direct agonism of serotonin 5-HT1A receptors.
C. Inhibition of monoamine oxidase.
D. Opiate receptor activation.
- Correct answer-: : A. Blockade of NMDA receptors.
Rationale: Ketamine's mechanism is unique. It blocks NMDA receptors on
inhibitory GABA neurons, causing disinhibition and a burst of glutamate. This
activates AMPA receptors, triggering BDNF release and synaptic plasticity in
mood-regulating circuits (mTOR pathway).
Section 5: Complex Infectious Disease & Stewardship
9. A patient with a history of recurrent Clostridioides difficile infection (rCDI) is
treated with fecal microbiota transplantation (FMT). The primary therapeutic
goal is to:
A. Directly deliver antibodies against C. difficile toxins.
B. Restore a diverse, protective gut microbiome to provide "colonization
